These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Subpopulations of lactotropes detected with the reverse hemolytic plaque assay show differential responsiveness to dopamine. Luque EH, Munoz de Toro M, Smith PF, Neill JD. Endocrinology; 1986 May; 118(5):2120-4. PubMed ID: 3084212 [Abstract] [Full Text] [Related]
24. Sodium ions: their role and mechanism of action in the control of prolactin release. Collu R, Lafond J, Marchisio AM, Eljarmak D, Ducharme JR. Endocrinology; 1984 Apr; 114(4):1302-7. PubMed ID: 6423371 [Abstract] [Full Text] [Related]
26. Activation of D2 dopamine receptors inhibits estrogen response element-mediated estrogen receptor transactivation in rat pituitary lactotrophs. Ishida M, Mitsui T, Izawa M, Arita J. Mol Cell Endocrinol; 2013 Aug 15; 375(1-2):58-67. PubMed ID: 23701824 [Abstract] [Full Text] [Related]
27. Effects of bromocriptine on hormone production and cell growth in cultured rat pituitary cells. Johansen PW, Haug E, Gautvik KM. Acta Endocrinol (Copenh); 1985 Oct 15; 110(2):200-6. PubMed ID: 4060970 [Abstract] [Full Text] [Related]
28. Inhibitory effects of bromocriptine on vascular smooth muscle cell proliferation. Zhang Y, Cincotta AH. Atherosclerosis; 1997 Aug 15; 133(1):37-44. PubMed ID: 9258405 [Abstract] [Full Text] [Related]
29. Bromocriptine inhibits growth hormone release from rat pituitary cells in primary culture. Cronin MJ, Thorner MO, Hellmann P, Rogol AD. Proc Soc Exp Biol Med; 1984 Feb 15; 175(2):191-5. PubMed ID: 6694976 [Abstract] [Full Text] [Related]
30. Involvement of phosphoinositide-3-kinase and p70 S6 kinase in regulation of proliferation of rat lactotrophs in culture. Kawashima K, Yamakawa K, Arita J. Endocrine; 2000 Dec 15; 13(3):385-92. PubMed ID: 11216652 [Abstract] [Full Text] [Related]
33. Active and total transforming growth factor-β1 are differentially regulated by dopamine and estradiol in the pituitary. Recouvreux MV, Guida MC, Rifkin DB, Becu-Villalobos D, Díaz-Torga G. Endocrinology; 2011 Jul 15; 152(7):2722-30. PubMed ID: 21521749 [Abstract] [Full Text] [Related]
34. Antisense strategy unravels a dopamine receptor distinct from the D2 subtype, uncoupled with adenylyl cyclase, inhibiting prolactin release from rat pituitary cells. Valerio A, Alberici A, Tinti C, Spano P, Memo M. J Neurochem; 1994 Apr 15; 62(4):1260-6. PubMed ID: 8133260 [Abstract] [Full Text] [Related]
35. A sensitive assay for studying dopaminergic activity in cultures of rat pituitary cells. Giacomelli S, Braghiroli L, Ponzianelli A, Koppenaal DW, De Feo G. J Pharm Pharmacol; 1997 Mar 15; 49(3):319-21. PubMed ID: 9231354 [Abstract] [Full Text] [Related]
37. Roles of dopamine 2 receptor isoforms and g proteins in ethanol regulated prolactin synthesis and lactotropic cell proliferation. Sengupta A, Sarkar DK. PLoS One; 2012 Mar 15; 7(9):e45593. PubMed ID: 23029123 [Abstract] [Full Text] [Related]
38. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion. Balsa JA, Sánchez-Franco F, Lorenzo MJ, Pazos F, Lara JI, Cacicedo L. Endocrinology; 1996 Feb 15; 137(2):508-13. PubMed ID: 8593796 [Abstract] [Full Text] [Related]
39. One minute of bromocriptine irreversibly inhibits prolactin release for hours. Cronin MJ, Evans WS, Thorner MO. Eur J Pharmacol; 1984 Mar 16; 99(1):85-90. PubMed ID: 6723793 [Abstract] [Full Text] [Related]
40. Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging. Chen YC, Choi JK, Andersen SL, Rosen BR, Jenkins BG. Psychopharmacology (Berl); 2005 Aug 16; 180(4):705-15. PubMed ID: 15536545 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]